• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在实验室比格犬中,双缺失型溶瘤痘苗病毒编码 CD40 配体的安全性和生物分布。

Safety and biodistribution of a double-deleted oncolytic vaccinia virus encoding CD40 ligand in laboratory Beagles.

机构信息

Department of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland; Cancer Gene Therapy Group, Department of Pathology and Transplantation Laboratory, Haartman Institute, University of Helsinki, Helsinki, Finland.

Finnish Centre for Laboratory Animal Pathology and Department of Veterinary Biosciences, Faculty of Veterinary Medicine, University of Helsinki , Helsinki, Finland.

出版信息

Mol Ther Oncolytics. 2014 Dec 10;1:14002. doi: 10.1038/mto.2014.2. eCollection 2014.

DOI:10.1038/mto.2014.2
PMID:27119092
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4782937/
Abstract

We evaluated adverse events, biodistribution and shedding of oncolytic vaccinia virus encoding CD40 ligand in two Beagles, in preparation for a phase 1 trial in canine cancer patients. Dog 1 received one dose of vaccinia virus and was euthanized 24 hours afterwards, while dog 2 received virus four times once weekly and was euthanized 7 days after that. Dogs were monitored for adverse events and underwent a detailed postmortem examination. Blood, saliva, urine, feces, and organs were collected for virus detection. Dog 1 had mild fever and lethargy while dog 2 experienced a possible seizure 5.5 hours after first virus administration. Viral DNA declined quickly in the blood after virus administration in both dogs but was still detectable 1 week later by quantitative polymerase chain reaction. Only samples taken directly after virus infusion contained infectious virus. Small amounts of viral DNA, but no infectious virus, were detected in a few saliva and urine samples. Necropsies did not reveal any relevant pathological changes and virus DNA was detected mainly in the spleen. The dogs in the study did not have cancer, and thus adverse events could be more common and viral load higher in dogs with tumors which allow viral amplification.

摘要

我们评估了在两只比格犬中表达 CD40 配体的溶瘤痘苗病毒的不良事件、生物分布和脱落情况,为犬科癌症患者的 I 期临床试验做准备。狗 1 接受了一剂痘苗病毒,24 小时后安乐死,而狗 2 每周接受一次病毒治疗,共四次,然后在 7 天后安乐死。对狗进行了不良事件监测,并进行了详细的尸检。采集血液、唾液、尿液、粪便和器官进行病毒检测。狗 1 有轻度发热和嗜睡,而狗 2 在第一次病毒给药后 5.5 小时出现可能的癫痫发作。在两只狗中,病毒给药后血液中的病毒 DNA 迅速下降,但通过定量聚合酶链反应仍可在 1 周后检测到。只有在病毒输注后直接采集的样本才含有感染性病毒。少数唾液和尿液样本中检测到少量的病毒 DNA,但没有检测到感染性病毒。尸检未发现任何相关的病理变化,病毒 DNA 主要在脾脏中检测到。研究中的狗没有癌症,因此在允许病毒扩增的肿瘤犬中,不良事件可能更常见,病毒载量也更高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922f/4782937/a2866b3bc0e7/mto20142-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922f/4782937/4125d9df9e11/mto20142-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922f/4782937/00054ad0c774/mto20142-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922f/4782937/fcd0d77a2054/mto20142-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922f/4782937/9f5ce40e161c/mto20142-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922f/4782937/1cdb10926eb7/mto20142-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922f/4782937/a2866b3bc0e7/mto20142-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922f/4782937/4125d9df9e11/mto20142-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922f/4782937/00054ad0c774/mto20142-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922f/4782937/fcd0d77a2054/mto20142-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922f/4782937/9f5ce40e161c/mto20142-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922f/4782937/1cdb10926eb7/mto20142-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922f/4782937/a2866b3bc0e7/mto20142-f6.jpg

相似文献

1
Safety and biodistribution of a double-deleted oncolytic vaccinia virus encoding CD40 ligand in laboratory Beagles.在实验室比格犬中,双缺失型溶瘤痘苗病毒编码 CD40 配体的安全性和生物分布。
Mol Ther Oncolytics. 2014 Dec 10;1:14002. doi: 10.1038/mto.2014.2. eCollection 2014.
2
Safety, biodistribution and viral shedding of oncolytic vaccinia virus TG6002 administered intravenously in healthy beagle dogs.静脉注射于健康比格犬的溶瘤痘苗病毒 TG6002 的安全性、生物分布和病毒脱落。
Sci Rep. 2021 Jan 26;11(1):2209. doi: 10.1038/s41598-021-81831-2.
3
Safety studies and viral shedding of intramuscular administration of oncolytic vaccinia virus TG6002 in healthy beagle dogs.健康比格犬肌内注射溶瘤痘苗病毒 TG6002 的安全性研究和病毒脱落。
BMC Vet Res. 2020 Aug 25;16(1):307. doi: 10.1186/s12917-020-02524-y.
4
Safety studies on intravenous administration of oncolytic recombinant vesicular stomatitis virus in purpose-bred beagle dogs.在专门培育的比格犬中进行溶瘤性重组水疱性口炎病毒静脉注射的安全性研究。
Hum Gene Ther Clin Dev. 2013 Dec;24(4):174-81. doi: 10.1089/humc.2013.165.
5
Attenuated Semliki Forest virus for cancer treatment in dogs: safety assessment in two laboratory Beagles.用于犬类癌症治疗的减毒塞姆利基森林病毒:两只实验比格犬的安全性评估
BMC Vet Res. 2015 Jul 28;11:170. doi: 10.1186/s12917-015-0498-2.
6
Correlative analysis from a phase I clinical trial of intrapleural administration of oncolytic vaccinia virus (Olvi-vec) in patients with malignant pleural mesothelioma.胸膜内注射溶瘤痘苗病毒(Olvi-vec)治疗恶性胸膜间皮瘤的 I 期临床试验的相关性分析。
Front Immunol. 2023 Feb 16;14:1112960. doi: 10.3389/fimmu.2023.1112960. eCollection 2023.
7
Virotherapy of canine tumors with oncolytic vaccinia virus GLV-1h109 expressing an anti-VEGF single-chain antibody.用表达抗 VEGF 单链抗体的溶瘤痘苗病毒 GLV-1h109 对犬肿瘤进行病毒疗法。
PLoS One. 2012;7(10):e47472. doi: 10.1371/journal.pone.0047472. Epub 2012 Oct 16.
8
Oncolytic reovirus therapy: Pilot study in dogs with spontaneously occurring tumours.溶瘤呼肠孤病毒疗法:对患有自发性肿瘤的犬类进行的初步研究。
Vet Comp Oncol. 2018 Jun;16(2):229-238. doi: 10.1111/vco.12361. Epub 2017 Oct 27.
9
Intensive ocular sampling for the detection of subclinical canine herpesvirus-1 shedding in dogs with experimentally-induced latent infection.对实验性潜伏感染犬进行亚临床犬疱疹病毒 1 脱落的密集眼部采样。
Vet Microbiol. 2021 Mar;254:109001. doi: 10.1016/j.vetmic.2021.109001. Epub 2021 Jan 27.
10
The effect of topical ocular corticosteroid administration in dogs with experimentally induced latent canine herpesvirus-1 infection.局部眼部皮质类固醇给药对实验性诱导潜伏犬疱疹病毒-1 感染犬的影响。
Exp Eye Res. 2010 Jun;90(6):711-7. doi: 10.1016/j.exer.2010.03.001. Epub 2010 Mar 16.

引用本文的文献

1
Engineered Oncolytic Adenoviruses: An Emerging Approach for Cancer Therapy.工程化溶瘤腺病毒:一种新兴的癌症治疗方法。
Pathogens. 2022 Oct 4;11(10):1146. doi: 10.3390/pathogens11101146.
2
Engineering strategies to enhance oncolytic viruses in cancer immunotherapy.工程策略增强溶瘤病毒在癌症免疫治疗中的作用。
Signal Transduct Target Ther. 2022 Apr 6;7(1):117. doi: 10.1038/s41392-022-00951-x.
3
Infection of non-cancer cells: A barrier or support for oncolytic virotherapy?非癌细胞的感染:溶瘤病毒疗法的障碍还是支持?

本文引用的文献

1
Actual insights into the clinical management of febrile seizures.对热性惊厥临床管理的实际见解。
Eur J Pediatr. 2014 Aug;173(8):977-82. doi: 10.1007/s00431-014-2269-7. Epub 2014 Jan 30.
2
A pRb-responsive, RGD-modified, and hyaluronidase-armed canine oncolytic adenovirus for application in veterinary oncology.一种用于兽医肿瘤学的、对视网膜母细胞瘤蛋白(pRb)有反应、经RGD修饰且携带透明质酸酶的犬溶瘤腺病毒。
Mol Ther. 2014 May;22(5):986-98. doi: 10.1038/mt.2014.7. Epub 2014 Jan 22.
3
CD40 ligand and tdTomato-armed vaccinia virus for induction of antitumor immune response and tumor imaging.
Mol Ther Oncolytics. 2022 Feb 12;24:663-682. doi: 10.1016/j.omto.2022.02.004. eCollection 2022 Mar 17.
4
Safety, biodistribution and viral shedding of oncolytic vaccinia virus TG6002 administered intravenously in healthy beagle dogs.静脉注射于健康比格犬的溶瘤痘苗病毒 TG6002 的安全性、生物分布和病毒脱落。
Sci Rep. 2021 Jan 26;11(1):2209. doi: 10.1038/s41598-021-81831-2.
5
Safety studies and viral shedding of intramuscular administration of oncolytic vaccinia virus TG6002 in healthy beagle dogs.健康比格犬肌内注射溶瘤痘苗病毒 TG6002 的安全性研究和病毒脱落。
BMC Vet Res. 2020 Aug 25;16(1):307. doi: 10.1186/s12917-020-02524-y.
6
Development of oncolytic virotherapy: from genetic modification to combination therapy.溶瘤病毒治疗的发展:从基因修饰到联合治疗。
Front Med. 2020 Apr;14(2):160-184. doi: 10.1007/s11684-020-0750-4. Epub 2020 Mar 7.
7
Maraba virus-vectored cancer vaccines represent a safe and novel therapeutic option for cats.马拉巴病毒载体癌症疫苗为猫提供了一种安全且新颖的治疗选择。
Sci Rep. 2017 Nov 16;7(1):15738. doi: 10.1038/s41598-017-15992-4.
8
Attenuated Semliki Forest virus for cancer treatment in dogs: safety assessment in two laboratory Beagles.用于犬类癌症治疗的减毒塞姆利基森林病毒:两只实验比格犬的安全性评估
BMC Vet Res. 2015 Jul 28;11:170. doi: 10.1186/s12917-015-0498-2.
用于诱导抗肿瘤免疫反应和肿瘤成像的CD40配体及携带tdTomato的痘苗病毒
Gene Ther. 2014 Feb;21(2):195-204. doi: 10.1038/gt.2013.73. Epub 2013 Dec 5.
4
Safety studies on intravenous administration of oncolytic recombinant vesicular stomatitis virus in purpose-bred beagle dogs.在专门培育的比格犬中进行溶瘤性重组水疱性口炎病毒静脉注射的安全性研究。
Hum Gene Ther Clin Dev. 2013 Dec;24(4):174-81. doi: 10.1089/humc.2013.165.
5
Oncolytic vaccines.溶瘤疫苗。
Expert Rev Vaccines. 2013 Oct;12(10):1155-72. doi: 10.1586/14760584.2013.836912.
6
Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial.腺病毒介导的基因治疗联合静脉用更昔洛韦治疗可切除的高级别脑胶质瘤患者(ASPECT):一项随机、开放标签、3 期临床试验。
Lancet Oncol. 2013 Aug;14(9):823-33. doi: 10.1016/S1470-2045(13)70274-2. Epub 2013 Jul 12.
7
Treatment efficacy and immune stimulation by AdCD40L gene therapy of spontaneous canine malignant melanoma.AdCD40L 基因治疗对自发性犬恶性黑色素瘤的治疗效果和免疫刺激作用。
J Immunother. 2013 Jul-Aug;36(6):350-8. doi: 10.1097/CJI.0b013e31829d8a1b.
8
The genomics of selection in dogs and the parallel evolution between dogs and humans.狗的选择基因组学和狗与人类之间的平行进化。
Nat Commun. 2013;4:1860. doi: 10.1038/ncomms2814.
9
A model of study for human cancer: Spontaneous occurring tumors in dogs. Biological features and translation for new anticancer therapies.人类癌症的研究模型:狗身上自发性发生的肿瘤。生物特征及对新抗癌疗法的转化。
Crit Rev Oncol Hematol. 2013 Oct;88(1):187-97. doi: 10.1016/j.critrevonc.2013.03.005. Epub 2013 Apr 3.
10
Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer.随机剂量探索性临床试验:溶瘤免疫治疗性痘苗病毒 JX-594 在肝癌中的应用。
Nat Med. 2013 Mar;19(3):329-36. doi: 10.1038/nm.3089. Epub 2013 Feb 10.